Carregant...
Oral Anticoagulation in Chronic Kidney Disease and Atrial Fibrillation: The Use of Non-Vitamin K-Dependent Anticoagulants and Vitamin K Antagonists
BACKGROUND: Cardiological societies recommend, in their guidelines, that patients with atrial fibrillation and an intermediate (or higher) risk of stroke and systemic embolization should be treated with oral anticoagulant drugs. For patients who do not have mitral valve stenosis or a mechanical valv...
Guardat en:
| Publicat a: | Dtsch Arztebl Int |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Deutscher Arzte Verlag
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5974258/ https://ncbi.nlm.nih.gov/pubmed/29789105 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3238/arztebl.2018.0287 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|